16-70514350-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_015386.3(COG4):c.529C>T(p.Arg177Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015386.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COG4 | NM_015386.3 | c.529C>T | p.Arg177Ter | stop_gained | 4/19 | ENST00000323786.10 | |
COG4 | NM_001195139.2 | c.517C>T | p.Arg173Ter | stop_gained | 4/18 | ||
COG4 | NM_001365426.1 | c.103C>T | p.Arg35Ter | stop_gained | 5/20 | ||
COG4 | NR_158212.1 | n.540C>T | non_coding_transcript_exon_variant | 4/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COG4 | ENST00000323786.10 | c.529C>T | p.Arg177Ter | stop_gained | 4/19 | 1 | NM_015386.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152018Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251420Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135884
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461852Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727232
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152018Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74246
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 02, 2022 | - - |
COG4-congenital disorder of glycosylation Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 01, 2014 | The Arg177X variant in COG4 has not been previously reported in individuals with congenital disorders of glycosylation or in large population studies. This nonsense variant leads to a premature termination codon at position 177 which is predicted to lead to a truncated or absent protein. Loss-of-function variants in COG4 have been described in individuals with congenital disorder of glycosylation type II (Reynders 2009, Ng 2011). In summary, although additional studies are required to fully establish its clinical significance, theArg177X variant is likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at